The Strategy of Antivirus Treatment in Reproductive Women Infected with Hepatitis B Virus
暂无分享,去创建一个
[1] M. Manns,et al. Treatment of chronic hepatitis B. , 2010, Minerva gastroenterologica e dietologica.
[2] Lin Shen,et al. The HBV drug entecavir - effects on HIV-1 replication and resistance. , 2007, The New England journal of medicine.
[3] J. Hoofnagle,et al. Management of hepatitis B: Summary of a clinical research workshop , 2007, Hepatology.
[4] H. Cai,et al. [The safety and effect of lamivudine in treating pregnant women infected with hepatitis B virus]. , 2006, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.
[5] De-zhong Xu,et al. Preliminary study on the efficacy and safety of lamivudine and interferon α therapy in decreasing serum HBV DNA level in HBV positive transgenic mice during pregnancy , 2005, Journal of medical virology.
[6] M. Foss,et al. Effect of maternal use of antiretroviral agents on serum insulin levels of the newborn infant. , 2005, Diabetes care.
[7] M. Senzolo,et al. Successful pregnancy in a liver transplant recipient treated with lamivudine for de novo hepatitis B in the graft , 2004, Transplant international : official journal of the European Society for Organ Transplantation.
[8] K. Nagashima,et al. Mitochondrial damage and DNA depletion in cord blood and umbilical cord from infants exposed in utero to Combivir , 2004, AIDS.
[9] K. Pan,et al. Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. , 2004, World journal of gastroenterology.
[10] H. Tilson,et al. Assessing the risk of birth defects associated with antiretroviral exposure during pregnancy. , 2003, American journal of obstetrics and gynecology.
[11] L. Schnaas,et al. Effects of prenatal exposure to Zidovudine and Lamivudine on brainstem auditory evoked potentials in infants from HIV-infected women. , 2004, Proceedings of the Western Pharmacology Society.
[12] L. Zou,et al. Interruption of HBV intrauterine transmission: a clinical study. , 2003, World journal of gastroenterology.
[13] H. Janssen,et al. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection , 2003, Journal of viral hepatitis.
[14] F. Denis,et al. Virus des hepatites : transmission mere-enfant , 2002 .
[15] S. Alain,et al. [Hepatitis viruses: mother to child transmission]. , 2002, Pathologie-biologie.
[16] E. Alleva,et al. Prenatal AZT or 3TC and mouse development of locomotor activity and hot-plate responding upon administration of the GABAA receptor agonist muscimol , 2001, Psychopharmacology.
[17] L. Mandelbrot,et al. Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women. , 2001, American journal of obstetrics and gynecology.
[18] E. Alleva,et al. Prenatal exposure to anti-HIV drugs: neurobehavioral effects of zidovudine (AZT) + lamivudine (3TC) treatment in mice. , 2001, Teratology.
[19] P. Rustin,et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues , 1999, The Lancet.
[20] E. Alleva,et al. Neurobehavioral effects of prenatal lamivudine (3TC) exposure in preweaning mice. , 1999, Neurotoxicology and teratology.
[21] G. E. Pakes,et al. Clinical Pharmacokinetics of Lamivudine , 1999, Clinical pharmacokinetics.
[22] P. Harrigan,et al. Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring. , 1998, The Journal of infectious diseases.